MichaelJGrantIIMD

PubMed

• 5 citations
  Co-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse Outcomes in Patients With EGFR-Mutant Lung Cancer.
  Paul Stockhammer, Michael Grant, Anna Wurtz, Giorgia Foggetti, Francisco Expósito, Jianlei Gu, Hongyu Zhao, Jungmin Choi, Sangyun Chung, Fangyong Li, Zenta Walther, Ju...> ;Journal of Thoracic Oncology. 2024 Feb 1
• Precise, pragmatic and inclusive: the modern era of oncology clinical trials.
  Michael J Grant, Sarah B Goldberg> ;Nature Medicine. 2023 Aug 1
• 5 citations
  Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations.
  Michael J Grant, Jacqueline V Aredo, Jacqueline H Starrett, Paul Stockhammer, Iris K van Alderwerelt van Rosenburgh, Anna Wurtz, Andrew J Piper-Valillo, Zofia Piotrows...> ;Clinical Cancer Research. 2023 Jun 1
• 1 citations
  The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer.
  Michael J Grant, Gavitt A Woodard, Sarah B Goldberg> ;Hematology/oncology Clinics of North America. 2023 Jun 1
• 7 citations
  Biochemical and structural basis for differential inhibitor sensitivity of EGFR with distinct exon 19 mutations.
  Iris K van Alderwerelt van Rosenburgh, David M Lu, Steven E Stayrook, Manali Phadke, Zenta Walther, Sarah B Goldberg, Katerina Politi, Mark A Lemmon, Kumar D Ashtekar,...> ;Nature Communications. 2022 Nov 10
• Yale Precision Medicine Tumor Board: reawakening the guardian of the genome.
  Michael J Grant, Karin E Finberg, Zenta Walther, Stacey M Stein, Jill Lacy, Joseph P Eder, Sarah B Goldberg> ;The Lancet. Oncology. 2022 Mar 1
• 4 citations
  Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary V...
  Richard L. Martin, Michael J. Grant, Stephen Kimani, Shonali Midha, Jori May, Rushad Patell, Emily F. Collier, David Furfaro, Charles Bodine, Leo Reap, Nikesh N. Shah,...> ;JCO Oncology Practice. 2021 Jul 9
• 128 citations
  Selecting the optimal immunotherapy regimen in driver-negative metastatic NSCLC.
  Michael J. Grant, Roy S. Herbst, Sarah B. Goldberg> ;Nature Reviews. Clinical Oncology. 2021 Jun 24
• Prolonged Complete Response of Early Stage Primary Adenocarcinoma of the Lung to Nivolumab Monotherapy.
  Serhan Unlu, Scott N. Gettinger, Adebowale J. Adeniran, Harriet M. Kluger> ;Clinical Oncology, Case Reports. 2021 Jan 1
• 2 citations
  Multiple Cranial Neuropathies as the Presenting Sign in a Patient with Metastatic BRAF-Mutated Lung Adenocarcinoma with Leptomeningeal Involvement.
  Bailey Gleason Fitzgerald, Gbambele J. Kone, Huned S. Patwa, Michal G. Rose> ;Case Reports in Oncology. 2020 Oct 15
• 5 citations
  Treatment with Foscarnet after Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Is Associated with Long-Term Loss of Renal Function
  Gena G. Foster, Samantha M. Thomas, Blake Cameron, Doug Raiff, Kelly Corbet, Christopher Ferreri, Mitchell E. Horwitz, Michael J. Grant, Gavin Loitsch> ;Biology of Blood and Marrow Transplantation. 2020 Sep 1
• Join now to see all